Appointment of Non-Executive Director
RNS Number : 6010H
Baronsmead Venture Trust PLC
04 August 2021
 

 

4 August 2021

 

 

Baronsmead Venture Trust plc

("BVT" or the "Company")

 

Appointment of Non-Executive Director

 

The Board of Baronsmead Venture Trust plc is pleased to announce the appointment of Ms Fiona Miller Smith as an independent Non-Executive Director of the Company and a member of the Audit Committee, Management Engagement & Remuneration Committee and Nomination Committee, with effect from 1 September 2021.

Ms Miller Smith is CEO of Barts Charity ("Barts"), a health foundation with a £500m financial investment and commercial property portfolio. Barts funds transformational medical research and innovation in healthcare delivery and technology. Fiona has over twenty five years' experience of investing in and leading growth companies. Her early career was in finance and private equity and she then had a successful entrepreneurial career prior to joining Barts in 2016.

Peter Lawrence, Chairman of the Company, commented on the appointment:

"I am delighted that Fiona has agreed to join us and welcome her to an already talented board. Her extensive knowledge and experience of early stage investing, ESG matters, and board governance will be of great benefit to us.  I am confident that her contribution will be of substantial value as we grow and continue to steer our successful VCT with optimism, through the uncertain times ahead."

 

There are no further items requiring disclosure under Listing Rule 9.6.13 regarding Ms Miller Smith's appointment.

 

 

 

 

For further information, please contact:

 

Baronsmead VCT Investor Relations

020 7382 0999

[email protected]

 

LEI: 213800VQ1PQHOJXDDQ88

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAZZLFBFVLBBBE